The South Dakota Department of Health (DOH) is inviting middle and high school students to participate in Scrubs Camps and Camp Meds, programs designed to introduce young people to careers in healthcare. Read More »

Bristol Myers Squibb and the National Community Pharmacists Association (NCPA) have announced a new partnership to improve heart health in rural areas of the United States. Read More »

A group of organizations representing independent pharmacies has filed a legal brief in support of Iowa's regulation of pharmacy benefit managers (PBMs), which is currently being challenged in federal court. Read More »

PCCA recognized four individuals for their contributions to pharmacy compounding during its ThinkNext: International Seminar 2025, held October 9-11 in The Woodlands, Texas. Read More »

PCCA has announced the release of UniFlow, a new powder excipient base designed for compounding triturations with highly potent, low-dose active pharmaceutical ingredients such as liothyronine sodium (T3) and levothyroxine sodium (T4). Read More »

All products regulated by the Food and Drug Administration (FDA) that are imported into the United States will now be subject to inspection, according to a new policy from US Customs and Border Protection (CBP). Read More »

Nominations are open for the 2026 National Association of Boards of Pharmacy (NABP) Leadership Awards. Read More »

The United States Department of Health and Human Services (HHS) has announced that vaccine manufacturers will be required to remove thimerosal, a mercury-based preservative, from all influenza vaccines distributed in the country. Read More »

In the first six months of 2025, more than 29 million people were impacted by data breaches at health care organizations. Read More »

An incident at an outpatient pharmacy led to a patient receiving the wrong dosage strength of traZODone due to a transcription error. Read More »

The Food and Drug Administration (FDA) has issued guidance for health care providers to contact patients who are currently taking unapproved animal-derived thyroid medications. Read More »

The Food and Drug Administration (FDA) has issued a warning regarding the use of unapproved versions of glucagon-like peptide-1 (GLP-1) receptor agonist drugs, which are often used for weight loss. Read More »

The Food and Drug Administration (FDA) has announced new requirements for labeling opioid pain medications. Read More »

The Food and Drug Administration (FDA) has created a "green list" import alert to prevent unverified glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredients (APIs) from entering the United States. Read More »

The National Community Pharmacists Association (NCPA) and HealthShifts have announced a partnership to enhance career and staffing support for community pharmacies. Read More »